Literature DB >> 28752346

Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman's disease.

Alvaro Ortiz1,2, Pedro Cárdenas3, Marcela Peralta4,3, Harold Rodríguez3, Gabriel Frederick3, Jacobo Ortiz4.   

Abstract

BACKGROUND: To report the neuro-ophthalmological findings in the TAFRO syndrome in a South American patient.
METHODS: This is a case report of a patient with TAFRO syndrome.
RESULTS: We present the case of a 66-year-old woman with TAFRO syndrome and multicentric Castleman disease, who developed ophthalmic manifestations, as a rare complication, including optic disk edema and serous retinal detachment, which improved with conventional therapy.
CONCLUSIONS: The optic disk edema could be present as a neuro-ophthalmological finding in TAFRO syndrome. To the best of our knowledge, this is the first report on the ophthalmic manifestations in the TAFRO syndrome.

Entities:  

Keywords:  Electrophysiology; Multicentric Castleman’s disease; Optic nerve disease; Thrombocytopenia

Mesh:

Year:  2017        PMID: 28752346     DOI: 10.1007/s10792-017-0636-x

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  17 in total

1.  Localized mediastinal lymphnode hyperplasia resembling thymoma.

Authors:  B CASTLEMAN; L IVERSON; V P MENENDEZ
Journal:  Cancer       Date:  1956 Jul-Aug       Impact factor: 6.860

2.  Castleman-Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature.

Authors:  Alessandro Allegra; Francesco Rotondo; Sabina Russo; Laura Calabrò; Valerio Maisano; Francesco Bacci; Caterina Musolino
Journal:  Blood Cells Mol Dis       Date:  2015-06-25       Impact factor: 3.039

3.  TAFRO syndrome: An atypical variant of KSHV-negative multicentric Castleman disease.

Authors:  Antonino Carbone; Liron Pantanowitz
Journal:  Am J Hematol       Date:  2016-02       Impact factor: 10.047

4.  Castleman-Kojima disease (TAFRO syndrome) : a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima (6 June, 2012) and Nagoya meetings (22 September, 2012).

Authors:  Hiroshi Kawabata; Kazue Takai; Masaru Kojima; Naoya Nakamura; Sadao Aoki; Shigeo Nakamura; Tomohiro Kinoshita; Yasufumi Masaki
Journal:  J Clin Exp Hematop       Date:  2013

5.  Aggressive TAFRO syndrome with reversible cardiomyopathy successfully treated with combination chemotherapy.

Authors:  Shunichiro Yasuda; Keisuke Tanaka; Ayako Ichikawa; Ken Watanabe; Emi Uchida; Masahide Yamamoto; Kouhei Yamamoto; Daisuke Mizuchi; Osamu Miura; Tetsuya Fukuda
Journal:  Int J Hematol       Date:  2016-05-31       Impact factor: 2.490

6.  Proposed diagnostic criteria, disease severity classification and treatment strategy for TAFRO syndrome, 2015 version.

Authors:  Yasufumi Masaki; Hiroshi Kawabata; Kazue Takai; Masaru Kojima; Norifumi Tsukamoto; Yasuhito Ishigaki; Nozomu Kurose; Makoto Ide; Jun Murakami; Kenji Nara; Hiroshi Yamamoto; Yoko Ozawa; Hidekazu Takahashi; Katsuhiro Miura; Tsutomu Miyauchi; Shinichirou Yoshida; Akihito Momoi; Nobuyasu Awano; Soichiro Ikushima; Yasunori Ohta; Natsue Furuta; Shino Fujimoto; Haruka Kawanami; Tomoyuki Sakai; Takafumi Kawanami; Yoshimasa Fujita; Toshihiro Fukushima; Shigeo Nakamura; Tomohiro Kinoshita; Sadao Aoki
Journal:  Int J Hematol       Date:  2016-03-18       Impact factor: 2.490

7.  Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience.

Authors:  Taxiarchis V Kourelis; Francis K Buadi; Shaji K Kumar; Morie A Gertz; Martha Q Lacy; David Dingli; Ronald S Go; Prashant Kapoor; John A Lust; Suzanne R Hayman; Yi Hwa; S Vincent Rajkumar; Steven R Zeldenrust; Stephen J Russell; Yi Lin; Nelson Leung; Robert A Kyle; Wilson I Gonsalves; Angela Dispenzieri
Journal:  Am J Hematol       Date:  2016-04-13       Impact factor: 10.047

Review 8.  TAFRO syndrome: 2 cases and review of the literature.

Authors:  Mikako Kawashima; Taro Usui; Hideyuki Okada; Ichiro Mori; Masahiro Yamauchi; Takahide Ikeda; Kazuo Kajita; Yusuke Kito; Tatsuhiko Miyazaki; Kei Fujioka; Tatsuo Ishizuka; Hiroyuki Morita
Journal:  Mod Rheumatol       Date:  2015-07-20       Impact factor: 3.023

Review 9.  TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.

Authors:  Kazuya Sakai; Takeshi Maeda; Akira Kuriyama; Noriaki Shimada; Kenji Notohara; Yasunori Ueda
Journal:  Mod Rheumatol       Date:  2016-02-17       Impact factor: 3.023

10.  TAFRO Syndrome Associated with EBV and Successful Triple Therapy Treatment: Case Report and Review of the Literature.

Authors:  Malorie Simons; Emmanuel Apor; James N Butera; Diana O Treaba
Journal:  Case Rep Hematol       Date:  2016-09-29
View more
  2 in total

1.  Severe refractory TAFRO syndrome requiring continuous renal replacement therapy complicated with Trichosporon asahii infection in the lungs and myocardial infarction: an autopsy case report and literature review.

Authors:  Arata Hibi; Ken Mizuguchi; Akiko Yoneyama; Takahisa Kasugai; Keisuke Kamiya; Keisuke Kamiya; Chiharu Ito; Satoru Kominato; Toshiyuki Miura; Katsushi Koyama
Journal:  Ren Replace Ther       Date:  2018-04-04

2.  An Autopsy Case of TAFRO Syndrome with Type II Respiratory Failure.

Authors:  Mikio Wada; Akihiro Nagata; Atsushi Kawashima; Keizo Kagawa
Journal:  Am J Case Rep       Date:  2020-10-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.